 |
|
|
||||||||||||||
 |
|
|
By developing new blood tests to identify people at high risk for devastating and preventable diseases, and utilizing dynamic protein and blood borne biomarkers, not genetics, we can arm patients and physicians with knowledge they can use to help prevent disease progression.
Our employees bring not only their individual capabilities, but also their inspired personal commitment to our mission of making a difference in the lives of patients suffering from chronic diseases.
Join our team and take part in changing the future of chronic disease.
See our current job openings or send your resume to jobs@tethysbio.com
Message to Staffing Vendors, Search Firms and Recruitment Agencies
Thank you for your interest in assisting Tethys Bioscience recruit outstanding prospective employees.
All staffing and recruiting processes at Tethys Bioscience are managed through the Human Resources department. Recruiters are not to initiate contact with any Tethys Bioscience employee in an attempt to present candidates. For candidates to be considered, they must first be presented to the on-site Tethys Bioscience recruiter after a signed agreement is in place.
Again, to protect the interests of all parties involved, Tethys requires a signed agreement to be in place before the presentation of any candidates. Tethys does not accept unsolicited resumes from staffing vendors, including recruitment agencies and/or search firms, and does not pay fees to any such vendor without a current contract on file. Tethys Bioscience does not accept unsolicited resumes from any source other than directly from candidates and will not pay a fee for any unsolicited resumes. There are no exceptions to this policy.
Any recruitment company interested in a business relationship with Tethys Bioscience should forward their information, including references, to jobs@tethysbio.com, or by fax to 510-450-0675, or to:
Human Resources
Tethys Bioscience
5858 Horton Street, Suite 550
Emeryville, CA 94608
Thank you again for your interest in helping Tethys Bioscience recruit exceptional additions to our team of talented, passionate and dedicated employees.
All information submitted is governed by our Privacy Policy.
Jul 22, 2010
Tethys Raises $33 Million
Tethys Bioscience, Inc., announced today that the company has recently raised $33 million, comprising $23 million of venture financing and a $10 million working capital loan.
Jul 14, 2010
Diabetes Risk, on a Scale of 1 to 10
A new test is transforming the way some doctors diagnose and treat their patients.
(Technology Review)
Jul 1, 2010
PreDx® featured on CBS Interactive's Smartplanet
CBS Interactive smartplanet video segment focuses on the impact of the PreDx® Diabetes Risk Score on the physician and patient.
Jun 24, 2010
Tethys Announces Issuance of Key Patent Relating to PreDx™ Diabetes Risk Score Test
United States Patent and Trademark Office grants patent to Tethys. The patent is directed to the company's groundbreaking PreDx™ Diabetes Risk Score (DRS) test and relates to proprietary methods for assessing the risk of developing a diabetic condition.
Nov 9, 2009
Tethys Bioscience Raises $25 Million in Series D Financing
The financing round is led by aeris Capital with George Rehm taking a seat on the Tethys board.
Oct 20, 2009
Gazing into the Future
(Journal of Life Sciences, Fall 2009)